Tag: TIGIT inhibitor clinical trials
iTeos ESMO Data: Promising Win for TIGIT in Nasdaq (ITOS)
iTeos Therapeutics (NASDAQ:ITOS) has been making significant strides in the field of immunotherapy, focusing on a molecule targeting TIGIT, a checkpoint with a complex...
Breaking Financial News
Understanding Deflation Trends in October 2024: A Comprehensive Chart Analysis
In October 2024, deflation trends have been observed in the U.S. economy, particularly in the prices of physical goods. While deflation is not a...
